“…The phenotype ranges from nonspecific developmental delay (Tabatabaie et al, 2011) to the severe lethal disease known as Neu–Laxova syndrome (NLS; MIM# 256520). Following the first descriptions by Neu and Laxova in 1971 and 1972, respectively (Laxova, Ohara, & Timothy, 1972; Neu, Kajii, Gardner, & Nagyfy, 1971), fewer than 100 cases of NLS have been reported to date (Acuna‐Hidalgo et al, 2014; Bourque et al, 2019; Cavole et al, 2020; Coto‐Puckett et al, 2010; El‐Hattab et al, 2016; Manning, Cunniff, Colby, El‐Sayed, & Hoyme, 2004; Mattos et al, 2015; Ni et al, 2019; Shaheen et al, 2014). The clinical hallmarks of this disorder are severe intrauterine growth restriction (IUGR), microcephaly, cutaneous abnormalities, and distinctive craniofacial features including sloping forehead, ocular hypertelorism, prominent eyes, ectropion, flat nose, round gaping mouth, micrognathia, short neck, and low‐set malformed ears.…”